Pediatric cancers in Bihar: A retrospective tertiary cancer center study

Avinash Pandey1, Anjana Singh1, Vijendra Kumar2

  • 1Department of Medical Oncology, State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.

Insights

Pediatric cancers in Bihar show a higher incidence in males. Acute lymphoblastic leukemia (ALL) and Hodgkin

Area of Science:

  • Pediatric Oncology
  • Cancer Epidemiology
  • Clinical Audit

Background:

  • Limited data exists on pediatric cancer distribution in Bihar.
  • Understanding cancer patterns is crucial for targeted interventions.

Purpose of the Study:

  • To identify and analyze the demographic data, types, and distribution patterns of pediatric cancers in Bihar.
  • To provide a comprehensive overview of the pediatric cancer landscape in the region.

Main Methods:

  • Retrospective clinical audit of pediatric cancer patients (0-18 years) from January 2018 to December 2018.
  • Data collected included age, sex, and cancer type, stratified into hematolymphoid and solid tumor cohorts.
  • Statistical analysis using SPSS version 17.0 for frequency distribution and descriptive statistics.

Main Results:

  • A total of 247 pediatric cancers were registered.
  • Hematolymphoid cancers (57%) were more common than solid cancers (43%).
  • Acute lymphoblastic leukemia (ALL) was the most frequent cancer (31%), followed by Hodgkin's lymphoma (19% of hematolymphoid).
  • Among solid tumors, Wilms' tumor (27%), Ewing's sarcoma (15%), and germ cell tumors (14%) were most common.

Conclusions:

  • Acute lymphoblastic leukemia (ALL) and Hodgkin's lymphoma are the predominant pediatric hematolymphoid malignancies.
  • Wilms' tumor, Ewing's sarcoma, and germ cell tumors are the most common solid pediatric cancers in Bihar.
Abstract

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
601
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
207